title: [Lipid behavior during hemodialysis using heparin and prostacyclin].
abstract: Ten patients have been studied for lipidic behaviour during hemodialysis using as anticoagulant heparin and prostacyclin. Hearing has been administered at infusion rate of 2000 U/h and prostacyclin in 5 ng/kg/min. Lipidic behaviour (before and after hemodialysis) has been studied for apolipoproteins A and B, total serum cholesterol and serum triglycerides, HDL-cholesterol, lipoprotein. Total serum cholesterol/HDL-cholesterol, apolipoproteins A/apolipoproteins B, apolipoproteins A/HDL-cholesterol ratios have been also studied. Our findings show that heparin produces acute changes in lipidic behaviour after hemodialysis and suggest that administrations may contribute to lipidic derangement of uremic dialytic patient while heparin free dialysis (prostacyclin infusion) doesn't show lipidic derangement after dialytic treatment. Prostacyclin infusion suggests that may be a useful anticoagulant and therapeutic drug especially in uremic dialytic subject with high atherosclerosis involvement, dyslipidemia and arterial hypertension.
authors: Metodologia Clinica, Università degli Studi, Pisa.
authors: M
authors: M
authors: Camici
authors: L
authors: L
authors: Evangelisti
mesh_terms: D000328:Adult; D001053:Apolipoproteins / Q000097:blood*; D002784:Cholesterol / Q000097:blood*; D011464:Epoprostenol / Q000494:pharmacology*; D005260:Female; D006493:Heparin / Q000494:pharmacology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D014280:Triglycerides / Q000097:blood*
chemical_list: D001053:Apolipoproteins; D014280:Triglycerides; D006493:Heparin; D002784:Cholesterol; D011464:Epoprostenol
vernacular_title: Comportamento lipidico durante emodialisi eseguita con eparina e con prostaciclina.